These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
450 related articles for article (PubMed ID: 19047161)
1. Tubulin-targeted drug action: functional significance of class ii and class IVb beta-tubulin in vinca alkaloid sensitivity. Gan PP; Kavallaris M Cancer Res; 2008 Dec; 68(23):9817-24. PubMed ID: 19047161 [TBL] [Abstract][Full Text] [Related]
2. Class III beta-tubulin mediates sensitivity to chemotherapeutic drugs in non small cell lung cancer. Gan PP; Pasquier E; Kavallaris M Cancer Res; 2007 Oct; 67(19):9356-63. PubMed ID: 17909044 [TBL] [Abstract][Full Text] [Related]
3. Combretastatin A-4 resistance in H460 human lung carcinoma demonstrates distinctive alterations in beta-tubulin isotype expression. Wehbe H; Kearney CM; Pinney KG Anticancer Res; 2005; 25(6B):3865-70. PubMed ID: 16309172 [TBL] [Abstract][Full Text] [Related]
4. Delineating the Role of βIV-Tubulins in Pancreatic Cancer: βIVb-Tubulin Inhibition Sensitizes Pancreatic Cancer Cells to Vinca Alkaloids. Sharbeen G; McCarroll J; Liu J; Youkhana J; Limbri LF; Biankin AV; Johns A; Kavallaris M; Goldstein D; Phillips PA Neoplasia; 2016 Dec; 18(12):753-764. PubMed ID: 27889644 [TBL] [Abstract][Full Text] [Related]
5. Specific β-tubulin isotypes can functionally enhance or diminish epothilone B sensitivity in non-small cell lung cancer cells. Gan PP; McCarroll JA; Byrne FL; Garner J; Kavallaris M PLoS One; 2011; 6(6):e21717. PubMed ID: 21738778 [TBL] [Abstract][Full Text] [Related]
6. Modulation of endogenous beta-tubulin isotype expression as a result of human beta(III)cDNA transfection into prostate carcinoma cells. Ranganathan S; McCauley RA; Dexter DW; Hudes GR Br J Cancer; 2001 Sep; 85(5):735-40. PubMed ID: 11531260 [TBL] [Abstract][Full Text] [Related]
7. Study of multi-drug resistant mechanisms in a taxol-resistant hepatocellular carcinoma QGY-TR 50 cell line. Zhou J; Cheng SC; Luo D; Xie Y Biochem Biophys Res Commun; 2001 Feb; 280(5):1237-42. PubMed ID: 11162660 [TBL] [Abstract][Full Text] [Related]
8. Direct analysis of tubulin expression in cancer cell lines by electrospray ionization mass spectrometry. Verdier-Pinard P; Wang F; Burd B; Angeletti RH; Horwitz SB; Orr GA Biochemistry; 2003 Oct; 42(41):12019-27. PubMed ID: 14556633 [TBL] [Abstract][Full Text] [Related]
9. Microtubule-damaging agents enhance RASSF1A-induced cell death in lung cancer cell lines. Whang YM; Park KH; Jung HY; Jo UH; Kim YH Cancer; 2009 Mar; 115(6):1253-66. PubMed ID: 19156899 [TBL] [Abstract][Full Text] [Related]
10. Comparison of beta-tubulin mRNA and protein levels in 12 human cancer cell lines. Hiser L; Aggarwal A; Young R; Frankfurter A; Spano A; Correia JJ; Lobert S Cell Motil Cytoskeleton; 2006 Jan; 63(1):41-52. PubMed ID: 16362954 [TBL] [Abstract][Full Text] [Related]
11. Markedly decreased binding of vincristine to tubulin in vinca alkaloid-resistant Chinese hamster cells is associated with selective overexpression of alpha and beta tubulin isoforms. Sirotnak FM; Danenberg KD; Chen J; Fritz F; Danenberg PV Biochem Biophys Res Commun; 2000 Mar; 269(1):21-4. PubMed ID: 10694470 [TBL] [Abstract][Full Text] [Related]
12. Regulation of class II beta-tubulin expression by tumor suppressor p53 protein in mouse melanoma cells in response to Vinca alkaloid. Arai K; Matsumoto Y; Nagashima Y; Yagasaki K Mol Cancer Res; 2006 Apr; 4(4):247-55. PubMed ID: 16603638 [TBL] [Abstract][Full Text] [Related]
13. Energetics of vinca alkaloid interactions with tubulin isotypes: implications for drug efficacy and toxicity. Lobert S; Frankfurter A; Correia JJ Cell Motil Cytoskeleton; 1998; 39(2):107-21. PubMed ID: 9484953 [TBL] [Abstract][Full Text] [Related]
14. Expression of beta-tubulin isotypes in human ovarian carcinoma xenografts and in a sub-panel of human cancer cell lines from the NCI-Anticancer Drug Screen: correlation with sensitivity to microtubule active agents. Nicoletti MI; Valoti G; Giannakakou P; Zhan Z; Kim JH; Lucchini V; Landoni F; Mayo JG; Giavazzi R; Fojo T Clin Cancer Res; 2001 Sep; 7(9):2912-22. PubMed ID: 11555610 [TBL] [Abstract][Full Text] [Related]
15. Potentiation of radiation therapy by vinorelbine (Navelbine) in non-small cell lung cancer. Edelstein MP; Wolfe LA; Duch DS Semin Oncol; 1996 Apr; 23(2 Suppl 5):41-7. PubMed ID: 8610236 [TBL] [Abstract][Full Text] [Related]
16. Escape from therapy-induced accelerated cellular senescence in p53-null lung cancer cells and in human lung cancers. Roberson RS; Kussick SJ; Vallieres E; Chen SY; Wu DY Cancer Res; 2005 Apr; 65(7):2795-803. PubMed ID: 15805280 [TBL] [Abstract][Full Text] [Related]
17. Paclitaxel and vincristine potentiate adenoviral oncolysis that is associated with cell cycle and apoptosis modulation, whereas they differentially affect the viral life cycle in non-small-cell lung cancer cells. AbouEl Hassan MA; Braam SR; Kruyt FA Cancer Gene Ther; 2006 Dec; 13(12):1105-14. PubMed ID: 16841078 [TBL] [Abstract][Full Text] [Related]
18. Novel mutations involving βI-, βIIA-, or βIVB-tubulin isotypes with functional resemblance to βIII-tubulin in breast cancer. Wang W; Zhang H; Wang X; Patterson J; Winter P; Graham K; Ghosh S; Lee JC; Katsetos CD; Mackey JR; Tuszynski JA; Wong GK; Ludueña RF Protoplasma; 2017 May; 254(3):1163-1173. PubMed ID: 27943021 [TBL] [Abstract][Full Text] [Related]
19. Resistance to the tubulin-binding agents in renal cell carcinoma: no mutations in the class I beta-tubulin gene but changes in tubulin isotype protein expression. Ferguson RE; Taylor C; Stanley A; Butler E; Joyce A; Harnden P; Patel PM; Selby PJ; Banks RE Clin Cancer Res; 2005 May; 11(9):3439-45. PubMed ID: 15867246 [TBL] [Abstract][Full Text] [Related]
20. Increased sensitivity to Vinca alkaloids in cells overexpressing calmodulin by gene transfection. Ido M; Lagacé L; Chafouleas JG Cancer Res; 1990 Oct; 50(20):6554-8. PubMed ID: 2208115 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]